NCT00089960View on ClinicalTrials.gov

Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)

PHASE2CompletedINTERVENTIONAL

Enrollment

138

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2008

Conditions

Gastrointestinal Cancer

Interventions

DRUG

AMG 706

AMG 706 125 mg daily for 48 weeks, or until progressive disease or unacceptable toxicity.

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY